AstraZeneca Shares Rise 7.65% to $187.75
AstraZeneca shares climbed 7.65% to $187.75 at 12:40 p.m. ET on October 30. Reuters reported a restructuring overhaul alongside quarterly results, with a $2 billion cost ceiling.
AstraZeneca NYSE:AZN, the global drugmaker, is putting a $2 billion restructuring bill behind its next growth push. Shares climbed 7.65% to $187.75 at 12:40 p.m. ET on October 30 as Reuters reported a spending overhaul alongside quarterly results. The prize is $1.5 billion in annualized pretax bene…